{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:40:26Z","timestamp":1760042426691},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T00:00:00Z","timestamp":1208304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The donation of ivermectin (Mectizan<jats:sup>\u00ae<\/jats:sup>, Merck &amp; Co., Inc.) to control onchocerciasis (river blindness) was established in 1987 and has since gradually expanded to provide for &gt;570 million treatments cumulatively over the past 20\u2003years. The Mectizan Donation Program (MDP) operates within a broad partnership in 33 endemic countries in need of mass treatment. Particular operational methods and tools are applied to facilitate ivermectin mass treatment. Drug management has been streamlined, including dosing, tablet size and packaging, and monitoring for adverse events. Much of the experience gained in the development of ivermectin mass treatment can be usefully applied in the recent broader perspective of control of neglected tropical diseases. The most important operational lessons of the MDP include: (i) the need to easily define the target population for treatment using rapid, non\u2010invasive techniques; (ii) the value of a broad partnership; (iii) the great potential of working through community\u2010directed treatment; (iv) the need to streamline all drug management aspects and (v) the importance of operations research to tackle new challenges.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2008.02049.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T12:50:39Z","timestamp":1280148639000},"page":"689-696","source":"Crossref","is-referenced-by-count":30,"title":["Operational lessons from 20\u2003years of the Mectizan Donation Program for the control of onchocerciasis"],"prefix":"10.1111","volume":"13","author":[{"given":"B.","family":"Thylefors","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Alleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A. Y.","family":"Twum\u2010Danso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,16]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"361","article-title":"Ivermectin dose assessment without weighing scales","volume":"71","author":"Alexander NDE","year":"1993","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-5-11"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349802125000664"},{"key":"e_1_2_10_5_1","article-title":"Ivermectin: possible neurotoxicity","volume":"5","author":"Anonymous","year":"1991","journal-title":"WHO Drug Information"},{"key":"e_1_2_10_6_1","volume-title":"APOC and the Millennium Development Goals","author":"APOC\/WHO","year":"2006"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1985.11811889"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91026-1"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1179\/136485906X112194"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034989859564"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01211.x"},{"key":"e_1_2_10_12_1","first-page":"129","article-title":"Comparaison entre differentes methods de depistage des grosseses au cours de traitements par ivermectine a large echelle au Cameroun","volume":"3","author":"Chippaux JP","year":"1995","journal-title":"Bulletin de la Societe de Pathologie Exotique"},{"key":"e_1_2_10_13_1","first-page":"27","article-title":"The Mectizan Donation Program \u2013 successful collaboration between the public and private sector","volume":"33","author":"Colatrella B","year":"2003","journal-title":"Drug Donations"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1353\/pbm.2004.0004"},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4269\/ajtmh.2005.73.1159","article-title":"Impact of ivermectin community\u2010level treatments on the elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year","volume":"73","author":"Cupp EW","year":"2005","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_10_16_1","first-page":"707","article-title":"Adverse reactions after large\u2010scale treatment of onchocerciasis with ivermectin: combined results from eight community trials","volume":"67","author":"De Sole G","year":"1989","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4922(02)02362-0"},{"key":"e_1_2_10_18_1","first-page":"105","article-title":"Effets secondaires du traitement de la loase hypermicrofilaremique par l\u2019ivermectine","volume":"88","author":"Ducorps M","year":"1995","journal-title":"Bulletin de la Societe de Pathologie Exotique"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09456-4"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-2276.2003.01142.x"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-2-S1-S10"},{"key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2005.72.1","article-title":"Whither onchocerciasis control in Africa?","volume":"72","author":"Hopkins DR","year":"2005","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_10_23_1","article-title":"Report of a scientific working group on serious adverse events following mectizan treatment of onchocerciasis in Loa loa endemic areas","volume":"2","author":"Mectizan Donation Program","year":"2003","journal-title":"Filaria Journal"},{"key":"e_1_2_10_24_1","volume-title":"A Manual for Rapid Epidemiological Mapping of Onchocerciasis","author":"Ngoumou P","year":"1993"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1994.11812893"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)93187-T"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01209.x"},{"key":"e_1_2_10_28_1","first-page":"255","volume-title":"Economics of Essential Medicines","author":"Sturchio JL","year":"2002"},{"key":"e_1_2_10_29_1","first-page":"267","article-title":"The selection of communities for treatment of onchocerciasis with ivermectin","volume":"43","author":"Taylor HR","year":"1992","journal-title":"Tropical Medicine & Parasitology"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01226.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1179\/136485906X112202"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01213.x"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2883-2-S1-S3"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349804225003208"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.3.463"},{"key":"e_1_2_10_36_1","volume-title":"Strategies for Invermectin Distribution through Primary Health Care Systems","author":"WHO","year":"1991"},{"key":"e_1_2_10_37_1","volume-title":"Onchocerciasis and Its Control; Report of a WHO Expert Committee on Onchocerciasis Control","author":"WHO","year":"1995"},{"key":"e_1_2_10_38_1","volume-title":"Preventive Chemotherapy in Human Helminthiasis","author":"WHO","year":"2006"},{"key":"e_1_2_10_39_1","volume-title":"Community\u2010Directed Treatment with Ivermectin","author":"WHO\/TDR","year":"1996"},{"key":"e_1_2_10_40_1","volume-title":"Implementation and Sustainability of Community\u2010Directed Treatment of Onchocerciasis with Ivermectin","author":"WHO\/TDR","year":"2000"},{"key":"e_1_2_10_41_1","volume-title":"Rapid Assessment Procedures for Loiasis","author":"WHO\/TDR","year":"2001"},{"key":"e_1_2_10_42_1","first-page":"384","article-title":"Can ivermectin mass treatment eliminate onchocerciasis?","volume":"80","author":"Winnen M","year":"2002","journal-title":"Bulletin of the World Health Organization"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2008.02049.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2008.02049.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:38:44Z","timestamp":1696898324000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2008.02049.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,16]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1365-3156.2008.02049.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2008.02049.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,16]]}}}